Adlai Nortye Ltd. Sponsored ADR ANL

Healthcare — Biotechnology

15.53 (0.30) (1.90%) as of 25 Sep

Market cap: $929.7M
P/E: —

Follow ANL

Dividend Champion (5y)

Growth Flags show if company had growth for consecutive years

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Dec '24	Jun '25	Dec '25	Jun '26
ROE Full definition →	+3 more TTM periods Free account	—	0.00%	0.00%	0.00%
ROA Full definition →		—	0.00%	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		—	—	—	0.00
Free Cash Flow per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow Full definition →		(155.67)	(151.96)	(129.37)	(115.75)
Capital Expenditures Full definition →		(0.50)	—	(0.60)	—
Piotroski F-Score Full definition →		0.00	0.00	0.00	0.00
Other line items
Cash ROIC Full definition →		(137.13%)	(132.58%)	(312.74%)	(24.44%)
Accounts Payable Turnover Full definition →		—	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		0.00	0.00	0.00	0.00
Depreciation/Fixed assets Full definition →		0.64	0.00	0.62	0.00
Capex/Depreciation Full definition →		(0.15)	—	(0.17)	—
Operating CF per Share Full definition →		0.00	0.00	0.00	0.00
Capex per Share Full definition →		0.00	—	0.00	—
Capex to Sales Full definition →		0.00	—	0.00	—

Fold the line items

Columns are period end dates